Journal Supplements

Proteasome inhibition in Hematologic Malignancies: Clinical Udate and Practical Applications. Oncology (Huntington). 2004;18(14 suppl 11):1-24. Copyright © 2004 CMP Healthcare.

Dalton WS. Proteasome inhibition in hematologic malignancies: clinical update and practical applications. Oncology (Huntington). 2004;18(14 suppl 11):3.

Jung L, Holle L, Dalton WS. Discovery, development, and clinical applications of bortezomib. Oncology (Huntington). 2004;18(14 suppl 11):4-13.

Schwartz R, Davidson T. Pharmacology, pharmacokinetics, and practical applications of bortezomib. Oncology (Huntington). 2004;18(14 suppl 11):14-21.

Continuing Pharmacy Education Information

1) Learning Objectives
2) Course Evaluation Form
3) Continuing Pharmacy Education Post-Test

High-dose interleukin-2 in metastatic disease: renal cell carcinoma and melanoma. Oncology (Huntington). 2002;16(11 suppl 13):1-20. Copyright © 2004 by CMP Healthcare.

Dutcher J.  High-Dose interleukin-2 in metastatic disease: renal cell carcinoma and melanoma. Oncology (Huntington). 2002;16(11 suppl 13):3.

Dutcher J.  Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma. Oncology (Huntington). 2002;16(11 suppl 13):4-10.

Schwartz RN, Stover L, Dutcher J.  Managing toxicities of high-dose interleukin-2. Oncology (Huntington). 2002;16(11 suppl 13):11-20.

Douillard J-Y.  Irinotecan: a new treatment in metastatic colorectal cancer. J Oncol Pharm Practice. 2000;6(3 suppl):S3-S9.

Crown J, Palmby W.  Docetaxel: use in non–small cell lung cancer and metastatic breast cancer and formulation update. J Oncol Pharm Practice. 2000;6(3 suppl):S10-S21.

Frame D. Introduction to taxane pharmacokinetics and pharmacodynamics. J Oncol Pharm Practice. 2000;6(3 suppl):S22-S27.

Valley A. A review of dolasetron as management of nausea and vomiting in cancer patients. J Oncol Pharm Practice. 2000;6(3 suppl):S28-S40.

Maxwell C, Viale PH. Cancer treatment-induced bone loss in patients with breast or prostate cancer. Oncol Nurs Forum. 2005;32(3):589-603.
Abstract reprinted with permissoin from the Oncology Nursing Society. Full article available to ONS members only.


Kuhn JG. Fluorouracil and the new oral fluorinated pyrimidines. Ann Pharmacother. 2001; 35: 217-227.

Treish I, Schwartz R, Lindley C. Phamacology and theraupeutic use of trastuzmab in breast cancer. Am J Health-Syst Pharm. 2000;57(22): 2063-2079 [November 15, 2000].

Original research

Israeli RS, Rosenberg SJ, Saltzstein DR, Gottesman JE, Goldstein HR, Hull GW, Tran DNH, Warsi GM, Lacerna L. The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy. Clin Genitourin Cancer. 2007;5:271-277.

Brufsky A, Harker WG, Beck JT, et al. Zoledronic acid inhibits letrozole–induced bone loss in postmenopausal women with early breast cancer. J Clin Oncol. 2007;25:829-836.

Vogel CL, Yanagihara RH, Wood AJ, etal. Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy. The Oncologist. 2004; 9:687-695.
Reprinted with permision from Alpha Med Press: www.theoncologist.com

Larkin JA, Montero JA.  Efficacy and safety of amphotericin B lipid complex for zygomycosis. Infect Med. 2003;20:201-206.

Mattiuzzi GN, Kantarrjian H, Faderl S, et al. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy. Cancer. 2004;100:581-589.
Reproduced with permission of John Wiley & Sons, Inc

Crawford J, Griffith N, Kloth D, Kolesar J, Vermeulen L. 2006 Oncology Pharmacy Update: The Use of Colony-Stimulating Factors and Erythropoietins for Cancer Patients.

Watcha MF. Antiemetic Drugs in the Prevention and Treatment of Postoperative Vomiting in Children.

Thrombolytics: Theraputic Class Review
ACPE Provider: Pharmacy Healthcare Solutions/AmerisourceBergen*

Low Molecular-Weight Heparins: Theraputic Class Review
ACPE Provider: Pharmacy Healthcare Solutions/AmerisourceBergen*

Newsletters

Summer 2008

Winter 2005

Fall 2004

Summer 2004

Spring 2004

Fall 2003

Summer 2003

Spring 2003